Privia Health Group, Inc. Earnings Per Share (Basic)
Privia Health Group, Inc. (PRVA) reported Earnings Per Share (Basic) of $0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Privia Health Group, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.07, a 250.00% increase year-over-year.
- Privia Health Group, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.02, a 33.33% decline year-over-year.
- Privia Health Group, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.07, a 102.89% increase year-over-year.
- Privia Health Group, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.06, a 100.00% increase year-over-year.
- Privia Health Group, Inc. earnings per share, basic for fiscal 2025 was $0.19, a 58.33% increase from fiscal 2024.
- Privia Health Group, Inc. earnings per share, basic for fiscal 2024 was $0.12, a 40.00% decline from fiscal 2023.
- Privia Health Group, Inc. earnings per share, basic for fiscal 2023 was $0.20.
- Privia Health Group, Inc. earnings per share, basic for fiscal 2022 was -$0.08.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.07 10-Q · filed 2026-08-06 | $0.10 10-Q · filed 2026-08-06 | $0.17 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.23 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | $0.02 10-Q · filed 2026-05-07 | $0.10 derived: net income ÷ weighted average shares · filed 2026-05-07 | $0.15 derived: net income ÷ weighted average shares · filed 2026-05-07 | $0.18 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | $0.07 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.13 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.15 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.19 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.06 10-Q · filed 2025-11-06 | $0.08 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.11 10-Q · filed 2025-11-06 | $0.15 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | $0.02 10-Q · filed 2026-08-06 | $0.06 10-Q · filed 2026-08-06 | $0.09 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.12 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | $0.03 10-Q · filed 2026-05-07 | $0.07 derived: net income ÷ weighted average shares · filed 2026-05-07 | $0.10 derived: net income ÷ weighted average shares · filed 2026-05-07 | $0.13 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.07 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.10 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.12 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.03 10-Q · filed 2025-11-06 | $0.06 derived: net income ÷ weighted average shares · filed 2025-11-06 | $0.08 10-Q · filed 2025-11-06 | $0.11 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-06-30 | $0.03 10-Q · filed 2025-08-07 | $0.05 10-Q · filed 2025-08-07 | $0.08 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.13 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-03-31 | $0.03 10-Q · filed 2025-05-08 | $0.05 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.10 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.16 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2023-12-31 | $0.02 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.07 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.13 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.20 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.05 10-Q · filed 2024-11-07 | $0.11 derived: net income ÷ weighted average shares · filed 2024-11-07 | $0.17 10-Q · filed 2024-11-07 | $0.33 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-06-30 | $0.06 10-Q · filed 2024-08-08 | $0.13 10-Q · filed 2024-08-08 | $0.28 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.30 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-03-31 | $0.06 10-Q · filed 2024-05-09 | $0.22 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.24 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.14 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2022-12-31 | $0.16 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.17 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.08 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.08 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.01 10-Q · filed 2023-11-03 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-11-03 | -$0.24 10-Q · filed 2023-11-03 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-06-30 | -$0.10 10-Q · filed 2023-08-03 | -$0.26 10-Q · filed 2023-08-03 | -$0.37 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-03-31 | -$0.16 10-Q · filed 2023-05-04 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.36 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.84 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.83 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.09 10-Q · filed 2022-11-10 | -$1.74 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.74 10-Q · filed 2022-11-10 | -$1.72 derived: net income ÷ weighted average shares · filed 2023-03-01 |
| 2021-06-30 | -$1.68 10-Q · filed 2022-08-11 | -$1.68 10-Q · filed 2022-08-11 | -$1.66 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$1.50 derived: net income ÷ weighted average shares · filed 2023-03-01 |
| 2021-03-31 | $0.06 10-Q · filed 2022-05-12 | $0.10 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.27 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.33 derived: net income ÷ weighted average shares · filed 2023-03-01 |
| 2020-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.21 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.27 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.33 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.17 10-Q · filed 2021-11-08 | $0.23 derived: net income ÷ weighted average shares · filed 2021-11-08 | $0.29 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.06 10-Q · filed 2021-08-09 | $0.11 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.06 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | $0.09 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |